All Stories

  1. Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics
  2. Cost Savings Associated With Fully Automated Digital Cognitive Behavioral Therapy for Insomnia Disorder (SleepioRx): A Matched Control Study of US Patients
  3. Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report
  4. A qualitative systematic review of the impact of hearing on quality of life
  5. Is anchoring at ‘dead’ a theoretical requirement for health state valuation?
  6. Author Reply
  7. Marginal cost per QALY estimates: What are they good for?
  8. Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years Gained
  9. This Dead or That Dead: Framing Effects in the Evaluation of Health States
  10. The impact of higher uptake of plant-based diets in England: model-based estimates of health care resource use and health-related quality of life
  11. Editorial: Opportunity costs in health care: cost-effectiveness thresholds and beyond
  12. Individualised variable-interval risk-based screening in diabetic retinopathy: the ISDR research programme including RCT
  13. Editorial: Advancements and challenges in cost and resource allocation: 2022
  14. Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
  15. NICE and the EQ-5D-5L: Ten Years Trouble
  16. Digital cognitive behavioural therapy for insomnia and primary care costs in England: an interrupted time series analysis
  17. Economic analyses of interventions for student mental health: protocol for a systematic review
  18. Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al.
  19. Digital cognitive behavioural therapy for insomnia and primary care costs in England: an interrupted time series analysis
  20. Exclusive human milk diet for very preterm babies in England: protocol for a cost-effectiveness and budget impact analysis
  21. Transparency in Decision Modelling: What, Why, Who and How?
  22. Individualised screening for diabetic retinopathy: the ISDR study—rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening
  23. OP60 Optimising Risk-Based Screening: The Case Of Diabetic Eye Disease
  24. PP71 Long-Term Evaluation Of Broad Mental Health Interventions: A Review
  25. Model Registration: A Call to Action
  26. Stratifying the NHS Diabetic Eye Screening Programme: into the unknown?
  27. RCT of a specialist depression service for persistent depression
  28. CBT for frequent attenders in primary care
  29. RCT of school-based programme for parents of children at risk of ADHD
  30. Long term economic evaluation of interventions targeting multiple mental health conditions: protocol for a rapid review of methods
  31. Long term economic evaluation of interventions targeting multiple mental health conditions: protocol for a rapid review of methods
  32. A randomised controlled trial of laser scanning and casting for the construction of ankle–foot orthoses
  33. Identifying Objects of Value at the End of Life
  34. Clinical characteristics of persistent frequent attenders in primary care: case–control study
  35. Protocol for a review of health state utility values for diabetic retinopathy
  36. Cost-effectiveness of home visits after stroke
  37. Costs of personality disorder treatment non-completion
  38. Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776
  39. The Relationship between Individual Risk and Cost-Effectiveness in Screening Interventions
  40. Home visits for patients with a stroke
  41. PATCHWORK study protocol